BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 29536528)

  • 1. CLCA2 epigenetic regulation by CTBP1, HDACs, ZEB1, EP300 and miR-196b-5p impacts prostate cancer cell adhesion and EMT in metabolic syndrome disease.
    Porretti J; Dalton GN; Massillo C; Scalise GD; Farré PL; Elble R; Gerez EN; Accialini P; Cabanillas AM; Gardner K; De Luca P; De Siervi A
    Int J Cancer; 2018 Aug; 143(4):897-906. PubMed ID: 29536528
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CTBP1/CYP19A1/estradiol axis together with adipose tissue impacts over prostate cancer growth associated to metabolic syndrome.
    Massillo C; Dalton GN; Porretti J; Scalise GD; Farré PL; Piccioni F; Secchiari F; Pascuali N; Clyne C; Gardner K; De Luca P; De Siervi A
    Int J Cancer; 2019 Mar; 144(5):1115-1127. PubMed ID: 30152543
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CTBP1 depletion on prostate tumors deregulates miRNA/mRNA expression and impairs cancer progression in metabolic syndrome mice.
    Dalton GN; Massillo C; Scalise GD; Duca R; Porretti J; Farré PL; Gardner K; Paez A; Gueron G; De Luca P; De Siervi A
    Cell Death Dis; 2019 Apr; 10(4):299. PubMed ID: 30931931
    [TBL] [Abstract][Full Text] [Related]  

  • 4. miR-875-5p counteracts epithelial-to-mesenchymal transition and enhances radiation response in prostate cancer through repression of the EGFR-ZEB1 axis.
    El Bezawy R; Cominetti D; Fenderico N; Zuco V; Beretta GL; Dugo M; Arrighetti N; Stucchi C; Rancati T; Valdagni R; Zaffaroni N; Gandellini P
    Cancer Lett; 2017 Jun; 395():53-62. PubMed ID: 28274892
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MiR-186-5p upregulation inhibits proliferation, metastasis and epithelial-to-mesenchymal transition of colorectal cancer cell by targeting ZEB1.
    Li J; Xia L; Zhou Z; Zuo Z; Xu C; Song H; Cai J
    Arch Biochem Biophys; 2018 Feb; 640():53-60. PubMed ID: 29325758
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The transcriptional factor ZEB1 represses Syndecan 1 expression in prostate cancer.
    Farfán N; Ocarez N; Castellón EA; Mejía N; de Herreros AG; Contreras HR
    Sci Rep; 2018 Jul; 8(1):11467. PubMed ID: 30065348
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Copy number gain of ZEB1 mediates a double-negative feedback loop with miR-33a-5p that regulates EMT and bone metastasis of prostate cancer dependent on TGF-β signaling.
    Dai Y; Wu Z; Lang C; Zhang X; He S; Yang Q; Guo W; Lai Y; Du H; Peng X; Ren D
    Theranostics; 2019; 9(21):6063-6079. PubMed ID: 31534537
    [No Abstract]   [Full Text] [Related]  

  • 8. A novel microRNA regulator of prostate cancer epithelial-mesenchymal transition.
    Bucay N; Bhagirath D; Sekhon K; Yang T; Fukuhara S; Majid S; Shahryari V; Tabatabai Z; Greene KL; Hashimoto Y; Shiina M; Yamamura S; Tanaka Y; Deng G; Dahiya R; Saini S
    Cell Death Differ; 2017 Jul; 24(7):1263-1274. PubMed ID: 28498363
    [TBL] [Abstract][Full Text] [Related]  

  • 9. miR-27b and miR-34a enhance docetaxel sensitivity of prostate cancer cells through inhibiting epithelial-to-mesenchymal transition by targeting ZEB1.
    Zhang G; Tian X; Li Y; Wang Z; Li X; Zhu C
    Biomed Pharmacother; 2018 Jan; 97():736-744. PubMed ID: 29102917
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CTBP1 and metabolic syndrome induce an mRNA and miRNA expression profile critical for breast cancer progression and metastasis.
    Farré PL; Scalise GD; Duca RB; Dalton GN; Massillo C; Porretti J; Graña K; Gardner K; De Luca P; De Siervi A
    Oncotarget; 2018 Mar; 9(17):13848-13858. PubMed ID: 29568399
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The miR-644a/CTBP1/p53 axis suppresses drug resistance by simultaneous inhibition of cell survival and epithelial-mesenchymal transition in breast cancer.
    Raza U; Saatci Ö; Uhlmann S; Ansari SA; Eyüpoğlu E; Yurdusev E; Mutlu M; Ersan PG; Altundağ MK; Zhang JD; Doğan HT; Güler G; Şahin Ö
    Oncotarget; 2016 Aug; 7(31):49859-49877. PubMed ID: 27409664
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA-132/212 Upregulation Inhibits TGF-β-Mediated Epithelial-Mesenchymal Transition of Prostate Cancer Cells by Targeting SOX4.
    Fu W; Tao T; Qi M; Wang L; Hu J; Li X; Xing N; Du R; Han B
    Prostate; 2016 Dec; 76(16):1560-1570. PubMed ID: 27527117
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dual regulation by microRNA-200b-3p and microRNA-200b-5p in the inhibition of epithelial-to-mesenchymal transition in triple-negative breast cancer.
    Rhodes LV; Martin EC; Segar HC; Miller DF; Buechlein A; Rusch DB; Nephew KP; Burow ME; Collins-Burow BM
    Oncotarget; 2015 Jun; 6(18):16638-52. PubMed ID: 26062653
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MiR-301a regulates E-cadherin expression and is predictive of prostate cancer recurrence.
    Nam RK; Benatar T; Wallis CJ; Amemiya Y; Yang W; Garbens A; Naeim M; Sherman C; Sugar L; Seth A
    Prostate; 2016 Jul; 76(10):869-84. PubMed ID: 26990571
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CtBP1 associates metabolic syndrome and breast carcinogenesis targeting multiple miRNAs.
    De Luca P; Dalton GN; Scalise GD; Moiola CP; Porretti J; Massillo C; Kordon E; Gardner K; Zalazar F; Flumian C; Todaro L; Vazquez ES; Meiss R; De Siervi A
    Oncotarget; 2016 Apr; 7(14):18798-811. PubMed ID: 26933806
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA alteration and putative target genes in high-grade prostatic intraepithelial neoplasia and prostate cancer: STAT3 and ZEB1 are upregulated during prostate carcinogenesis.
    Cha YJ; Lee JH; Han HH; Kim BG; Kang S; Choi YD; Cho NH
    Prostate; 2016 Jul; 76(10):937-47. PubMed ID: 27017949
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Double-negative feedback loop between ZEB2 and miR-145 regulates epithelial-mesenchymal transition and stem cell properties in prostate cancer cells.
    Ren D; Wang M; Guo W; Huang S; Wang Z; Zhao X; Du H; Song L; Peng X
    Cell Tissue Res; 2014 Dec; 358(3):763-78. PubMed ID: 25296715
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA-137 targets carboxyl-terminal binding protein 1 in melanoma cell lines.
    Deng Y; Deng H; Bi F; Liu J; Bemis LT; Norris D; Wang XJ; Zhang Q
    Int J Biol Sci; 2011 Jan; 7(1):133-7. PubMed ID: 21278922
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA-27a-5p regulation by promoter methylation and MYC signaling in prostate carcinogenesis.
    Barros-Silva D; Costa-Pinheiro P; Duarte H; Sousa EJ; Evangelista AF; Graça I; Carneiro I; Martins AT; Oliveira J; Carvalho AL; Marques MM; Henrique R; Jerónimo C
    Cell Death Dis; 2018 Feb; 9(2):167. PubMed ID: 29415999
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LncRNA UCA1 sponges miR-204-5p to promote migration, invasion and epithelial-mesenchymal transition of glioma cells via upregulation of ZEB1.
    Liang C; Yang Y; Guan J; Lv T; Qu S; Fu Q; Zhao H
    Pathol Res Pract; 2018 Sep; 214(9):1474-1481. PubMed ID: 30107990
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.